A look at what the Contemporary Pediatrics team covered this week.
This week’s top articles included:
Getting comfortable having "the talk" with teen patients
Helen C. Wang, MD, shares key takeaways from the session she co-presented at PAS 2022.
Is there room for improvement in neuroimage use in suspected abuse cases in infants?
When an infant presents with fractures that suggest possible abuse, but appears to be neurologically fine, clinicians should make sure to rule out occult head injury. A report looks at whether many children’s hospitals are routinely following this guidance.
Exploring the link between kids with ADHD and unhealthy eating
The loss of a parent as a child is a traumatic experience. Exposure to A recent study found a negative association between children with attention-deficit/hyperactivity disorder (ADHD) and health eating patterns.
Will primary prevention strategies reduce the incidence of cannabinoid hyperemesis syndrome?
It may not be included in the differential diagnosis and can seem like it's cyclic vomiting syndrome, but a cannabinoid hyperemesis syndrome diagnosis can be found through diligent history and compassionate care.
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
Study finds reduced CIN3+ risk from early HPV vaccination
April 17th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.